Search Results - O. V. Isaeva
- Showing 1 - 7 results of 7
-
1
Plagiarism and “self-plagiarism” in scientific works in the age of digital technologies by M. A. Rozhkova, O. V. Isaeva
Published 2022-07-01As well as streamlining academic research activities, contemporary technologies provide opportunities to infringe on the intellectual property of others through plagiarism. However, plagiarism has yet to be adequately dealt with in national legislations, which either do not contain any provision in...
Get full text
Article -
2
Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteins by V. S. Kichatova, A. A. Karlsen, O. V. Isaeva, S. A. Solonin, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhailov
Published 2018-12-01Aim. To determine the prevalence of amino acid substitutions in hepatitis C virus NS5a and core proteins which are associated with resistance to direct-acting antivirals and interferon in genotype 1b (HCV-1b) strains circulating in Russia. Materials and methods. Nucleotide sequences of NS5a (n=93) a...
Get full text
Article -
3
Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan by S. A. Magomedova, V. V. Makashova, E. A. Arbulieva, Z. G. Tagirova, A. A. Karlsen, M. A. Lopatukhina, O. V. Isaeva, K. K. Kyuregyan, M. I. Mikhailov
Published 2023-10-01Aim: The analysis of the incidence of hepatitis B in the Republic of Dagestan (RD) and clinical and epidemiological characteristics of HBV/HDV coinfection in the region.Materials and Methods. The dynamics of the hepatitis B incidence rates and the coverage of vaccination against this infection in th...
Get full text
Article -
4
Dynamic changes in the prevalence of markers of hepatitis C virus infection among the conditionally healthy population of the Tyva Republic by A. A. Saryglar, O. V. Isaeva, V. S. Kichatova, M. A. Lopatukhina, I. A. Potemkin, A. A. Кarlsen, L. Yu. Ilchenko, K. K. Kyuregyan, M. I. Mikhailov
Published 2024-01-01The aim is to determine the dynamic changes in the prevalence of hepatitis C virus (HCV) infection among various age groups of the conditionally healthy population of the Tyva Republic over the past 11 years.Material and methods. 1163 serum samples collected in 2019 from the healthy volunteers livin...
Get full text
Article -
5
Peculiarity of Clinical Course of Childhood Hepatitis C Depending on the Viral Genotype by E. A. Leybman, L. I. Nikolaeva, E. I. Samokhvalov, K. K. Kyuregayn, O. V. Isaeva, G. V. Sapronov, T. V. Cherednechenko, A. G. Pisarev, A. E. Grishechkin, M. I. Michailov, V. F. Uchaikin
Published 2015-02-01Hepatitis C is a serious problem for Russian Federation. Determination of HCV genotype/subtype is needed for epidemic control, development of antiviral drugs, vaccines, and planning expenditures for treatment. The aims of the study were to establish the structure of HCV genotype in infected children...
Get full text
Article -
6
The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation by N. V. Soboleva, A. A. Karlsen, T. V. Kozhanova, V. S. Kichatova, V. V. Klushkina, O. V. Isaeva, M. E. Ignatieva, V. V. Romanenko, N. D. Oorzhak, E. Yu. Malinnikova, K. K. Kuregyan, M. I. Mikhailov
Published 2017-06-01Aim. To determine the prevalence of hepatitis C virus (HCV) in different age groups of the conditionally healthy population of Russia.Materials and methods. Total 4764 serum samples from a conditionally healthy population of five regions of Russia (Moscow, Rostov, Sverdlovsk regions, Tyva Republic,...
Get full text
Article -
7
Results of the Campaign Dedicated to World Hepatitis Day by V. V. Klushkina, Z. S. Rodionova, T. V. Tyrgina, E. V. Tivanova, I. V. Solovieva, V. V. Orlov, L. V. Telminova, E. B. Lapteva, R. S. Amirov, V. S. Kichatova, F. A. Asadi Mobarhan, A. A. Karlsen, O. V. Isaeva, A. N. Gerasimov, S. N. Kuzin, K. K. Kyuregyan, M. I. Mikhailov, V. G. Akimkin
Published 2025-07-01Introduction. The main measure to combat hepatitis C in the framework of its elimination plan is the “test and treat strategy”, as well as dissemination of knowledge on hepatitis C virus (HCV) infection among population. In order to raise awareness and increase the coverage with viral hepatitis test...
Get full text
Article